GILD - Gilead Sciences Inc. (GILD) Leerink Partners Global Biopharma Conference (Transcript)
2024-03-12 20:26:02 ET
Gilead Sciences, Inc. (GILD)
Leerink Partners Global Biopharma Conference
March 12, 2024 10:00 AM ET
Company Participants
Cindy Perettie - EVP, Kite
Conference Call Participants
Daina Graybosch - Leerink Partners
Presentation
Daina Graybosch
Okay. Good morning, everyone. My name is Daina Graybosch. I am an analyst here at Leerink Partners. My team and I cover immuno-oncology and broader. And we -- one of the companies we cover is Gilead, and we're really excited today to host Cindy Perettie from Kite.
Cindy Perettie
Thank you. It's nice to be here.
Question-and-Answer Session
Q - Daina Graybosch
And so we're going to jump right in, because it's a busy year and busy week for CAR T. And we're going to talk all elements. So actually, let's start with BCMA.
Cindy Perettie
Okay.
Daina Graybosch
So Kite has licensed Arcellx's BCMA CAR-T called Anito-Cel. And I wonder if you could talk about of all the potentially differentiating product attributes for Anito-Cel, which do you think will be most impactful in commercialization?...
Gilead Sciences, Inc. (GILD) Leerink Partners Global Biopharma Conference (Transcript)